Get started
Author

Sukhmani Sidhu

ORCID: 0009-0000-0519-4121
Observed ORCID: 0009-0000-0519-4121
OpenAlex ID: A5074185145
Adherence to Iron Chelation Therapy and Its Determinants
2021 · Sukhmani Sidhu, Shruti Kakkar, et al. · International Journal of Hematology-Oncology and Stem Cell Research · 20
Beliefs regarding SARS-COV-2 vaccine in patients with transfusion-dependent thalassemia
2022 · Shruti Kakkar, Pranjl Sharma, et al. · International Journal of Research in Medical Sciences · 2
PDF
Bayesian estimation of generalized gamma shared frailty model
2017 · Sukhmani Sidhu, Kanchan Jain, et al. · Computational Statistics · 2
Home isolation in transfusion-dependent thalassemia patients with SARS CoV2 infection: Experience from a developing country
2022 · Shruti Kakkar, Vaneet Anand, et al. · Pediatric Hematology Oncology Journal · 1
PDF
The Generalized Gamma Shared Frailty Model under Different Baseline Distributions
2019 · Sukhmani Sidhu, Kanchan Jain, et al. · International Journal of Mathematical Engineering and Management Sciences · 1
PDF
Mast cell leukemia with complex genomic alterations in an elderly patient with prior hematologic and solid malignancies: a case report
2026 · Angad Tiwari, Ashish Sharma, et al. · Annals of Medicine and Surgery
MM-1205: Minimal Residual Disease Negativity in Newly Diagnosed Multiple Myeloma: From Surrogate Endpoint Validation to the Unanswered Question of Maintenance-Free Remission
2026 · Ashish Sharma, Sukhmani Sidhu, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: MM-1183: Disparities in ASCT and CAR-T Access in Multiple Myeloma: Evidence From Real-World Studies in the Era of Novel Therapies
2026 · Ashish Sharma, Saloni Haldule, et al. · Clinical Lymphoma Myeloma & Leukemia
MM-1189: Early Intervention vs Observation in High-Risk Smoldering Multiple Myeloma: Pooled Evidence From Randomized Trials and Real-World Cohorts
2026 · Ashish Sharma, Sukhmani Sidhu, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: MM-1174: Infectious Morbidity With Bispecific T-Cell Engager Antibody Therapy in Relapsed/Refractory Multiple Myeloma: A Systematic Synthesis Revealing a Preventable Survival Gap
2026 · Ashish Sharma, Saloni Haldule, et al. · Clinical Lymphoma Myeloma & Leukemia
MM-1706: Multiple Myeloma Incidence and PM2.5 Pollution Levels (2003–2011) in the New England Region Compared to the Rest of the United States
2026 · Sukhmani Sidhu, Ashish Sharma, et al. · Clinical Lymphoma Myeloma & Leukemia
MM-1174: Infectious Morbidity With Bispecific T-Cell Engager Antibody Therapy in Relapsed/Refractory Multiple Myeloma: A Systematic Synthesis Revealing a Preventable Survival Gap
2026 · Ashish Sharma, Saloni Haldule, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: MM-1205: Minimal Residual Disease Negativity in Newly Diagnosed Multiple Myeloma: From Surrogate Endpoint Validation to the Unanswered Question of Maintenance-Free Remission
2026 · Ashish Sharma, Sukhmani Sidhu, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: MM-1706: Multiple Myeloma Incidence and PM2.5 Pollution Levels (2003–2011) in the New England Region Compared to the Rest of the United States
2026 · Sukhmani Sidhu, Ashish Sharma, et al. · Clinical Lymphoma Myeloma & Leukemia
MM-1183: Disparities in ASCT and CAR-T Access in Multiple Myeloma: Evidence From Real-World Studies in the Era of Novel Therapies
2026 · Ashish Sharma, Saloni Haldule, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: MM-1189: Early Intervention vs Observation in High-Risk Smoldering Multiple Myeloma: Pooled Evidence From Randomized Trials and Real-World Cohorts
2026 · Ashish Sharma, Sukhmani Sidhu, et al. · Clinical Lymphoma Myeloma & Leukemia
Fecal Immunochemical Test and Multitarget Stool DNA Testing for Colorectal Cancer Screening in Real-World Practice: A Literature Review
2026 · Ashish Sharma, Angad Tiwari, et al. · Journal of Clinical Medicine
PDF
Geographic and rural–urban patterns in pediatric and AYA malignant brain tumor mortality in the United States: A CDC WONDER analysis.
2026 · Angad Tiwari, Harendra Kumar, et al. · Journal of Clinical Oncology
Liquid biopsy at the finish line: End-of-treatment ctDNA predicts relapse and survival in diffuse large B-cell lymphoma.
2026 · Ashish Sharma, Harendra Kumar, et al. · Journal of Clinical Oncology
National inpatient outcomes and hospital-volume disparities after glioma resection: A HCUP NIS analysis.
2026 · Sukhmani Sidhu, Harendra Kumar, et al. · Journal of Clinical Oncology
PDF
National trends and racial disparities in diffuse large B-cell lymphoma mortality in the United States, 1999–2023.
2026 · Harendra Kumar, Ashish Sharma, et al. · Journal of Clinical Oncology
ctDNA versus PET/CT at end of treatment in large B-cell lymphoma: A diagnostic accuracy meta-analysis.
2026 · Ashish Sharma, Harendra Kumar, et al. · Journal of Clinical Oncology
Neurocognitive outcomes after proton versus photon radiotherapy in pediatric CNS tumors: Systematic review and meta-analysis.
2026 · Saloni Haldule, Harendra Kumar, et al. · Journal of Clinical Oncology
Extent of resection and survival in IDH -mutant WHO grade 2 glioma: A systematic review and meta-analysis.
2026 · Sukhmani Sidhu, Ashish Sharma, et al. · Journal of Clinical Oncology
From solid organ malignancies to dual leukaemias: sequential CLL and CML in a cancer survivor
2026 · Sukhmani Sidhu, Ramzi Hamouche, et al. · European Journal of Case Reports in Internal Medicine
PDF
Works count: 31
Citation count: 26
H-index: 2
I10-index: 1
Year
Topic
Type